PROCEPT BioRobotics (PRCT) Trading at 4.5x Sales Amid Growth
Published on · Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowAs of June 17, PROCEPT BioRobotics Corporation (PRCT) shares traded at $20.91. The company reported quadrupled revenues since 2022, currently growing at approximately 30% year-over-year. Despite this growth, PRCT trades at 4.5 times sales, while peers like Intuitive Surgical (ISRG) previously traded in a range of 9-18 times sales. Analysts project that PRCT could see approximately 150% appreciation over three years if growth patterns similar to ISRG continue, although short-term sentiment remains mixed due to slightly below-expectation revenue guidance.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Intuitive Surgical Inc. (ISRG)
Intuitive Surgical makes the da Vinci robotic-surgery systems.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier ISRG news
- Medtronic (MDT) Gains FDA Approval for New Robotic Surgery Platform
- Intuitive Surgical (ISRG) Trading at $483.46 with P/E Ratios of 59.99 and 47.39
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
